Concepedia

Lihui Xu

LX

Statistics

Publications

9

Citations

1K

H-Index

9

Active since

1999

Affiliations

Merrimack Pharmaceuticals (United States)(Current)

University of California, San Francisco

Lihui Xu is an author at Merrimack Pharmaceuticals (United States) specializing in pharmacy, antibody discovery, and antibody engineering.

Publications per year

1999–2019

9

Publications

9

Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis

Birgit Schoeberl, Emily A. Pace, Jonathan B. Fitzgerald et al. · Science Signaling · 2009 · 368 citations

Life Sciences, Cell Biology, Molecular Biology +17

Directed Evolution of High-Affinity Antibody Mimics Using mRNA Display

Lihui Xu, Patti Aha, Ke Gu et al. · Chemistry & Biology · 2002 · 250 citations · Full text

Pharmacy, Immunology, Molecular Biology +12

MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors

Jonathan B. Fitzgerald, Bryan W. Johnson, Jason Baum et al. · Molecular Cancer Therapeutics · 2013 · 102 citations

Life Sciences, Oncology, Pharmacology +17

Empty and Peptide-Loaded Class II Major Histocompatibility Complex Proteins Produced by Expression inEscherichia coliand Foldingin Vitro

Mia Frayser, Aaron K. Sato, Lihui Xu et al. · Protein Expression and Purification · 1999 · 96 citations

Life Sciences, Immunology, Molecular Biology +9

A novel screening method to assess developability of antibody-like molecules

Neeraj Kohli, Melissa L. Geddie, Maja Razlog et al. · mAbs · 2015 · 77 citations · Full text

Pharmacy, Biotechnology, Immunology +17

1–5 of 9